Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,755.20
(
-0.17%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.43
(
-2.02%
)
Bitcoin
69,826.50
(
-1.97%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 78238

Friday, 06/05/2009 2:39:58 AM

Friday, June 05, 2009 2:39:58 AM

Post# of 257262
IDIX Major Shareholders

[Updated for small “true up” purchase by NVS on 5/29/09.
The denominator used for the percentages shown below is 59.1M,
the number of common shares outstanding today rather than the
63M fully-diluted figure I use for valuation purposes (#msg-37350098).
JP Sommadossi owns 1.8M options plus the 2.2.M shares shown below.]
 
                        Shares  Stake 
 Novartis            31,317,393 53.0% 
 MPM Capital          3,321,534  5.6% 
 GlaxoSmithKline      2,474,527  4.2% 
 JP Sommadossi (CEO)  2,219,754  3.8%


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now